ATE556134T1 - Mesenchymstammzellen und verwendungendafür - Google Patents
Mesenchymstammzellen und verwendungendafürInfo
- Publication number
- ATE556134T1 ATE556134T1 AT05725577T AT05725577T ATE556134T1 AT E556134 T1 ATE556134 T1 AT E556134T1 AT 05725577 T AT05725577 T AT 05725577T AT 05725577 T AT05725577 T AT 05725577T AT E556134 T1 ATE556134 T1 AT E556134T1
- Authority
- AT
- Austria
- Prior art keywords
- stem cells
- methods
- animal
- mesenchymal stem
- mesenchyma stem
- Prior art date
Links
- 210000003716 mesoderm Anatomy 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 210000001557 animal structure Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 | |
| PCT/US2005/008506 WO2005093044A1 (en) | 2004-03-22 | 2005-03-15 | Mesenchymal stem cells and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE556134T1 true ATE556134T1 (de) | 2012-05-15 |
Family
ID=46060822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05725577T ATE556134T1 (de) | 2004-03-22 | 2005-03-15 | Mesenchymstammzellen und verwendungendafür |
Country Status (5)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (enExample) |
| AT (1) | ATE556134T1 (enExample) |
| CA (3) | CA3135582A1 (enExample) |
| ES (7) | ES2544689T3 (enExample) |
| TR (1) | TR201901268T4 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2544689T3 (es) * | 2004-03-22 | 2015-09-02 | Mesoblast International Sàrl | Células madre mesenquimales y usos de las mismas |
| WO2005093044A1 (en) * | 2004-03-22 | 2005-10-06 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| WO2014098960A2 (en) * | 2012-05-16 | 2014-06-26 | The Johns Hopkins University | Stem cells as an individualized maternal therapy for prevention of prematurity |
| JP2016210730A (ja) * | 2015-05-08 | 2016-12-15 | 上田 実 | 医薬組成物及びその製造方法並びに医薬品 |
| US11401502B2 (en) | 2016-11-15 | 2022-08-02 | Kaneka Corporation | Cell population comprising mesenchymal stem cells derived from fetal appendage, method for producing the same, and pharmaceutical composition |
| AU2018372631B2 (en) | 2017-11-22 | 2025-06-05 | Mesoblast International Sarl | Cellular compositions and methods of treatment I |
| WO2019132026A1 (ja) | 2017-12-28 | 2019-07-04 | 株式会社カネカ | 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物 |
| EP3984596A4 (en) | 2019-06-14 | 2023-06-21 | Kaneka Corporation | POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF |
| CA3148582A1 (en) * | 2019-08-15 | 2021-02-18 | Nextcell Pharma Ab | Allogeneic composition for treatment of cns disorders |
| CN113813288B (zh) * | 2021-08-11 | 2024-02-13 | 谢岩 | 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (ja) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | ガンマ・インターフェロン組成物 |
| WO1987005518A1 (en) * | 1986-03-17 | 1987-09-24 | Schering Corporation | Treatment of cancers with gamma interferon |
| AU2701895A (en) * | 1994-06-07 | 1996-01-05 | Regents Of The University Of Minnesota | Methods for inhibiting antigen specific t cell responses |
| JP2000508922A (ja) * | 1996-04-26 | 2000-07-18 | ケース ウエスターン リザーブ ユニバーシティ | 間葉幹細胞を用いる皮膚再生 |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| DE69929681T2 (de) * | 1998-03-18 | 2006-10-26 | Osiris Therapeutics, Inc. | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen |
| JP2002510655A (ja) * | 1998-04-03 | 2002-04-09 | オシリス セラピューティクス，インコーポレイテッド | 免疫抑制剤としての間葉幹細胞によるｔ細胞応答を阻害する方法とその利用 |
| AU2925401A (en) * | 2000-01-19 | 2001-07-31 | Parkash S Gill | Methods and compositions for antisense vegf oligonucleotides |
| DE60143517D1 (de) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | Wiederherstellung der gelenken mit mesenchymalen stammzellen |
| MXPA04007426A (es) * | 2002-02-01 | 2004-10-11 | Schering Corp | Usos de citosina de mamifero; reactivos relacionados. |
| JP3897343B2 (ja) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
| EP1583422B1 (en) * | 2002-12-05 | 2016-03-30 | Case Western Reserve University | Cell-based therapies for ischemia |
| WO2005093044A1 (en) * | 2004-03-22 | 2005-10-06 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| ES2544689T3 (es) * | 2004-03-22 | 2015-09-02 | Mesoblast International Sàrl | Células madre mesenquimales y usos de las mismas |
-
2005
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/es not_active Expired - Lifetime
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/es not_active Expired - Lifetime
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/es not_active Expired - Lifetime
- 2005-03-15 CA CA2868733A patent/CA2868733C/en not_active Expired - Lifetime
- 2005-03-15 ES ES14172800T patent/ES2708627T3/es not_active Expired - Lifetime
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/tr unknown
- 2005-03-15 AT AT05725577T patent/ATE556134T1/de active
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/es not_active Expired - Lifetime
- 2005-03-15 CA CA2934682A patent/CA2934682C/en not_active Expired - Lifetime
- 2005-03-15 ES ES05725577T patent/ES2385450T3/es not_active Expired - Lifetime
- 2005-03-15 ES ES14172807T patent/ES2657382T5/es not_active Expired - Lifetime
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/ja not_active Expired - Lifetime
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/ja not_active Expired - Lifetime
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/ja not_active Expired - Lifetime
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/ja not_active Expired - Lifetime
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/ja not_active Expired - Lifetime
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/ja not_active Expired - Lifetime
-
2021
- 2021-08-30 JP JP2021140167A patent/JP7546239B2/ja not_active Expired - Lifetime
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019014747A (ja) | 2019-01-31 |
| JP6382360B2 (ja) | 2018-08-29 |
| JP2017080507A (ja) | 2017-05-18 |
| CA2868733A1 (en) | 2005-10-06 |
| CA2934682C (en) | 2021-12-07 |
| CA2934682A1 (en) | 2005-10-06 |
| JP6757300B2 (ja) | 2020-09-16 |
| CA3135582A1 (en) | 2005-10-06 |
| ES2657382T3 (es) | 2018-03-05 |
| JP2015061862A (ja) | 2015-04-02 |
| HK1205677A1 (en) | 2015-12-24 |
| ES2708627T3 (es) | 2019-04-10 |
| JP5997237B2 (ja) | 2016-09-28 |
| JP6114500B2 (ja) | 2017-04-12 |
| ES2643030T3 (es) | 2017-11-21 |
| JP7546239B2 (ja) | 2024-09-06 |
| JP2012176948A (ja) | 2012-09-13 |
| JP2018009002A (ja) | 2018-01-18 |
| JP2021191771A (ja) | 2021-12-16 |
| JP2023065486A (ja) | 2023-05-12 |
| JP7033159B2 (ja) | 2022-03-09 |
| ES2643076T3 (es) | 2017-11-21 |
| HK1205531A1 (en) | 2015-12-18 |
| ES2385450T3 (es) | 2012-07-25 |
| JP2020111591A (ja) | 2020-07-27 |
| CA2868733C (en) | 2019-12-17 |
| TR201901268T4 (tr) | 2019-02-21 |
| ES2657382T5 (es) | 2021-07-12 |
| JP6757383B2 (ja) | 2020-09-16 |
| ES2544689T3 (es) | 2015-09-02 |
| ES2645018T3 (es) | 2017-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2298863A3 (en) | Mesenchymal stem cells and uses therefor | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| EP4438721A3 (en) | Mesenchymal stem cells and uses therefor | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| EA200700886A1 (ru) | Соединение тиадиазола и его применение | |
| EA200971053A1 (ru) | Способы лечения кожных язв | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
| EA201301078A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| GT200500260A (es) | Amidas biciclicas como inhibidores de cinasa. | |
| CR20120490A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| DE602007004615D1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| EA200970110A1 (ru) | Производные 6,9-дизамещённого пурина и их применение для лечения кожи | |
| MX2010009623A (es) | Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| DE602004024037D1 (de) | Substituierte heterozyklen | |
| MX2010009625A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
| ATE516366T1 (de) | Regulierte aptamer-therapeutika | |
| ATE556134T1 (de) | Mesenchymstammzellen und verwendungendafür |